Johnson & Johnson (NYSE:JNJ)

Why These 3 Biotechs More Than Doubled on Monday

Posted: December 9, 2019 at 10:40 am

Monday was a breakout day for a few biotech companies. Some made absolutely massive runs, practically doubling and then some. The biotechnology sector is pushing near all-time highs, and a ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Amarin, Baker Hughes, Canopy Growth, Home Depot, Intelsat, J&J, Replimune, Schlumberger, Transocean and More

Posted: November 20, 2019 at 8:55 am

Markets have hit new highs recently, but the main indexes were all marginally lower on Wednesday morning. With the Dow Jones industrials up over 28,000 and the S&P 500 over ...
Read Full Story »

How Dow 28,000 Can Rapidly Become Dow 30,000 and Even Higher in 2020

Posted: November 18, 2019 at 10:50 am

Investors love seeing the stock market hit new highs. It's impressive enough for the Dow Jones industrial average to have hit 28,000 and for the S&P 500 to have hit ...
Read Full Story »

As the Dow Hits All-Time High, Over Half of Dow Stocks Keep Disappointing Investors

Posted: November 4, 2019 at 11:20 am

When investors hear that the stock market just hit a new all-time high, it's probably fairly easy to assume that this means almost all the individual stocks are probably at ...
Read Full Story »

Why Goldman Sachs Enhanced Income Strategy May Be Perfect for 2020

Posted: November 4, 2019 at 6:50 am

Even though the S&P 500 now sits at all-time highs after over 10 years of a bull market, the venerable index still offers a 1.9% dividend yield and 6% expected ...
Read Full Story »

J&J Gets $10 Billion Gift as Lab Results Show No Asbestos in Baby Powder

Posted: October 29, 2019 at 5:12 pm
Last updated: October 30, 2019 7:22 am

Johnson & Johnson (NYSE: JNJ) has found itself involved in more controversy than the company would prefer to see. The consumer and health products company has been dogged in the ...
Read Full Story »

How Biotech and Big Pharma Have Upside Heading Into Earnings

Posted: October 19, 2019 at 6:45 am

Biotech and many of the so-called Big Pharma have been duds in 2019. Despite many FDA approvals and some powerful mergers and royalty deals, the political pressure around drug pricing ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Adobe, Alibaba, Amazon, AT&T, Comcast, Delphi, DocuSign, J&J, JPMorgan, T-Mobile, Verizon, Wells Fargo and More

Posted: October 16, 2019 at 8:45 am
Last updated: October 17, 2019 8:18 am

Stocks were indicated to open marginally lower on Wednesday, even after overseas markets were modestly higher. Investors are having to grapple with a slower economy at the same time that ...
Read Full Story »

Johnson & Johnson Offers a Strong Start to Earnings Season

Posted: October 15, 2019 at 10:29 am

When Johnson & Johnson (NYSE: JNJ) reported its most recent quarterly results before the markets opened on Tuesday, the pharmaceutical giant said it had $2.12 in earnings per share (EPS) ...
Read Full Story »

What to Expect When Johnson & Johnson Reports Tuesday

Posted: October 14, 2019 at 12:10 pm

Johnson & Johnson (NYSE: JNJ) is scheduled to report its most recent quarterly results before the markets open on Tuesday. The consensus estimates are calling for $2.00 in earnings per ...
Read Full Story »

Coca-Cola, Goldman Sachs, IBM, Johnson & Johnson and More Dow Stocks Reporting This Week

Posted: October 13, 2019 at 6:50 am

Seven of the 30 Dow Jones industrial average components are scheduled to report their latest quarterly reports this week. The Dow is hovering near its all-time high, just as this ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Apple, Canopy Growth, CrowdStrike, Delta, J&J, Rio Tinto, Roku, Square, Tilray, Twilio and More

Posted: October 11, 2019 at 8:50 am

Stocks were indicated to open sharply higher on Brexit hopes and U.S./China trade hopes, and earnings season will kick off next week. The bull market is now well over 10 ...
Read Full Story »